Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210394
Company: AJANTA PHARMA LTD

Products on ANDA 210394

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 210394

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/04/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 210394

SILDENAFIL CITRATE

TABLET;ORAL; EQ 20MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
REVATIO	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	Yes	AB	021845	VIATRIS
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	210394	AJANTA PHARMA LTD
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	202025	AMNEAL PHARMS
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	203963	AUROBINDO PHARMA LTD
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	202598	CHARTWELL RX
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	203623	HETERO LABS LTD V
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	203814	MACLEODS PHARMS LTD
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	204883	RUBICON
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	078380	TEVA PHARMS
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	091479	TORRENT PHARMS LTD
SILDENAFIL CITRATE	SILDENAFIL CITRATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	202503	WATSON LABS INC